IPM Biotech

Hamburg, Germany Founded: 2008 • Age: 18 yrs Acquired By BioAgilytix
Biomarkers, cytometry, PCR, and ELISA machines are manufactured.

About IPM Biotech

IPM Biotech is a Healthcare company based in Hamburg (Germany) founded in 2008, and was acquired by BioAgilytix in February 2016. Biomarkers, cytometry, PCR, and ELISA machines are manufactured. Its chief executive, as recorded, is Euan Menzies.

Company details

IPM Biotech was established in 2008 in Hamburg, Germany, within the biotechnology sector. Equipment for cytometry, PCR, and ELISA, along with biomarkers, is produced by the company. Operations are centered on supplying tools for laboratory and research applications in medical diagnostics. The firm is led by CEO Euan Menzies, with activities based in Germany to serve European markets.

Key Metrics

Investors in IPM Biotech

IPM Biotech has secured backing from 1 investor. Prominent investors backing the company include BioAgilytix.

All
InvestorDescriptionFounded YearDomainLocation
Large-molecule bioanalysis is provided for biologics and biosimilars development.
2008bioagilytix.comDurham, United States
Premium access

Investor details for IPM Biotech

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of IPM Biotech

1 people are tracked at IPM Biotech (1 in leadership).

NameRoleGroup
Euan Menzies
CEOLeadership
Premium access

Complete people profiles for IPM Biotech

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of IPM Biotech

2 dated milestones of IPM Biotech across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded IPM Biotech is founded.
  2. Exit Acquired by BioAgilytix.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about IPM Biotech

IPM Biotech was founded in 2008.

IPM Biotech is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.

Euan Menzies is the CEO of IPM Biotech, as recorded in our data.

IPM Biotech was established in 2008 in Hamburg, Germany, within the biotechnology sector. Equipment for cytometry, PCR, and ELISA, along with biomarkers, is produced by the company. Operations are centered on supplying tools for laboratory and research applications in medical diagnostics. The firm is led by CEO Euan Menzies, with activities based in Germany to serve European markets.

IPM Biotech has 1 investor. Key investors include BioAgilytix.

Yes. IPM Biotech was acquired by BioAgilytix in February 2016.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available